Gut peptides and the regulation of appetite

Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
M S B HudaJ H Pinkney

Abstract

There is a growing worldwide epidemic of obesity. Obese people have a higher incidence of type 2 diabetes and cardiovascular disease, and hence present increasing social, financial and health burdens. Weight loss is always difficult to achieve through lifestyle changes alone, and currently licensed anti-obesity drug treatments, such as orlistat and sibutramine, if tolerated, only achieve modest weight loss. Therefore, there is a need to identify more potent pharmacological targets. In the last 10 years, discoveries of new hormones such as leptin and ghrelin, together with greater understanding of previously described hormones such as cholecystokinin (CCK), pancreatic polypeptide (PP), peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), have led to a rapid increase in our knowledge of the regulation of energy balance. Among the most important factors, controlling appetite and satiety are peptide hormones released from the gut. In this paper, we provide a full up-to-date overview of the current state of knowledge of this field, together with the potential of these peptides as drugs, or as other therapeutic targets, in the treatment of obesity. Finally, we propose an integrated model to describe the complex interplay of these ho...Continue Reading

References

Feb 1, 1979·Diabetologia·W Creutzfeldt
Jan 22, 1977·Lancet·T E AdrianR C Russell
Jan 1, 1979·Scandinavian Journal of Gastroenterology·J J HolstH C Klein
Mar 1, 1978·The Journal of Clinical Investigation·T W SchwartzF Stadil
Nov 1, 1992·The American Journal of the Medical Sciences·D C Whitcomb, I L Taylor
Aug 11, 1992·Pharmacology, Biochemistry, and Behavior·K E AsinA M Nadzan
May 1, 1991·Clinical Science·G WilliamsS R Bloom
Jan 1, 1992·The American Journal of Clinical Nutrition·A M UheG P Young
Jun 1, 1991·Physiology & Behavior·C Erlanson-AlbertssonG A Bray
Oct 1, 1990·The American Journal of Physiology·J J CarsonS J Dixon
Sep 1, 1989·Digestive Diseases and Sciences·B SchjoldagerJ J Holst
Jul 13, 1987·FEBS Letters·T P MommsenE M Plisetskaya
Jan 1, 1988·Physiology & Behavior·N MuurahainenF X Pi-Sunyer
Nov 1, 1987·Gastroenterology·T L AbellA R Zinsmeister
Nov 1, 1985·Gastroenterology·T E AdrianS R Bloom
Oct 1, 1985·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·I M VarndellJ M Polak
Jan 1, 1985·Journal of Psychiatric Research·J T AlderdiceC Adams
Jan 1, 1985·Metabolism: Clinical and Experimental·R L GingerichW A Bauman
Jun 1, 1985·Physiology & Behavior·I L TaylorJ Elashoff
Feb 1, 1981·The American Journal of Clinical Nutrition·H R KissileffG P Smith
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K Tatemoto
Aug 1, 1980·Metabolism: Clinical and Experimental·P J HornnesT W Schwartz
Jun 1, 1981·The Journal of Clinical Endocrinology and Metabolism·W B ZipfJ Sotos
Sep 1, 1982·Peptides·L J Stein, S C Woods

❮ Previous
Next ❯

Citations

Aug 22, 2008·The Proceedings of the Nutrition Society·Susan Carnell, Jane Wardle
Apr 26, 2012·Critical Reviews in Food Science and Nutrition·E Van KleefC Zondervan
Sep 14, 2007·International Journal of Clinical Practice·R P Vincent, C W le Roux
May 18, 2011·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Jennifer L ReedNancy I Williams
Apr 24, 2008·Annual Review of Nutrition·Stephen C WoodsDaniela Cota
May 26, 2011·American Journal of Physiology. Endocrinology and Metabolism·Brenna R HillNancy I Williams
May 22, 2008·The Journal of Clinical Endocrinology and Metabolism·Erik IngelssonRamachandran S Vasan
Aug 24, 2012·Disease Models & Mechanisms·Jonathan C K Wells
Sep 10, 2008·PloS One·Alma FulurijaPhilippe Saudan
Jul 6, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xiaosong MaFrances M Ashcroft
Oct 24, 2012·F1000 Medicine Reports·James A Madura, John K Dibaise
Jan 1, 2013·Gastroenterology Research and Practice·Blaire AndersonMichel Gagner
Dec 11, 2007·Obesity Surgery·Fàtima Sabench PereferrerDaniel del Castillo Déjardin
May 6, 2014·Endocrine·Jing MaWei Liu
Oct 6, 2014·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Malin WerlingTorsten Olbers
Oct 14, 2008·Expert Opinion on Biological Therapy·Nicole C KestyDavid Maggs
May 25, 2012·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Emilio González Jiménez
Mar 2, 2011·Progress in Lipid Research·Jessica E StewartRussell S J Keast
Mar 12, 2010·The Veterinary Clinics of North America. Small Animal Practice·Dong Yong Kil, Kelly S Swanson
Jan 19, 2010·Nutrition·Carine De VrieseChristine Delporte
Mar 17, 2009·Nutrition Research·Holly J WillisJoanne L Slavin
Apr 3, 2008·Mayo Clinic Proceedings·John K DiBaiseBruce E Rittmann
Apr 22, 2008·European Journal of Pharmacology·Deborah Gustafson
Oct 27, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M E J Lean, D Malkova
Mar 10, 2016·Hormone Molecular Biology and Clinical Investigation·Heather C M AllawayMary Jane De Souza
Sep 3, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P EnckB Otto
Nov 23, 2007·Clinical Endocrinology·Lindsay K EllerRaylene A Reimer
May 19, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M Camilleri, A B M Grudell
Feb 5, 2011·Diabetes/metabolism Research and Reviews·Haiko SchloeglMichael Stumvoll
Feb 20, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·N WeltensL Van Oudenhove
Aug 9, 2013·Neuromodulation : Journal of the International Neuromodulation Society·Xiaotuan ZhaoJiande D Z Chen
Oct 9, 2015·Obesity Surgery·Charlotte de JongeJan Willem M Greve

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

The Journal of Clinical Endocrinology and Metabolism
Byung-Joon KimJosephine M Egan
The Journal of Clinical Endocrinology and Metabolism
Madhusmita MisraAnne Klibanski
The Journal of Clinical Endocrinology and Metabolism
P T PflugerM H Tschöp
Pharmacology & Therapeutics
Marianne T Neary, Rachel L Batterham
British Journal of Clinical Pharmacology
Benjamin C T FieldStephen R Bloom
© 2022 Meta ULC. All rights reserved